Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 39

Cited In for PubMed (Select 21403020)

1.

Conscientiousness, dementia related pathology, and trajectories of cognitive aging.

Wilson RS, Boyle PA, Yu L, Segawa E, Sytsma J, Bennett DA.

Psychol Aging. 2015 Mar;30(1):74-82. doi: 10.1037/pag0000013. Epub 2015 Feb 9.

PMID:
25664558
2.

Attempted and successful compensation in preclinical and early manifest neurodegeneration - a review of task FMRI studies.

Scheller E, Minkova L, Leitner M, Klöppel S.

Front Psychiatry. 2014 Sep 29;5:132. doi: 10.3389/fpsyt.2014.00132. eCollection 2014. Review.

3.

Cognitive changes preceding clinical symptom onset of mild cognitive impairment and relationship to ApoE genotype.

Albert M, Soldan A, Gottesman R, McKhann G, Sacktor N, Farrington L, Grega M, Turner R, Lu Y, Li S, Wang MC, Selnes O.

Curr Alzheimer Res. 2014;11(8):773-84.

4.

Early life instruction in foreign language and music and incidence of mild cognitive impairment.

Wilson RS, Boyle PA, Yang J, James BD, Bennett DA.

Neuropsychology. 2015 Mar;29(2):292-302. doi: 10.1037/neu0000129. Epub 2014 Aug 11.

PMID:
25110933
5.

Gray and white matter changes in subjective cognitive impairment, amnestic mild cognitive impairment and Alzheimer's disease: a voxel-based analysis study.

Kiuchi K, Kitamura S, Taoka T, Yasuno F, Tanimura M, Matsuoka K, Ikawa D, Toritsuka M, Hashimoto K, Makinodan M, Kosaka J, Morikawa M, Kichikawa K, Kishimoto T.

PLoS One. 2014 Aug 5;9(8):e104007. doi: 10.1371/journal.pone.0104007. eCollection 2014.

6.

Clinical-pathologic study of depressive symptoms and cognitive decline in old age.

Wilson RS, Capuano AW, Boyle PA, Hoganson GM, Hizel LP, Shah RC, Nag S, Schneider JA, Arnold SE, Bennett DA.

Neurology. 2014 Aug 19;83(8):702-9. doi: 10.1212/WNL.0000000000000715. Epub 2014 Jul 30.

PMID:
25080520
7.

Follow-up evaluation of cognitive function in the randomized Alzheimer's Disease Anti-inflammatory Prevention Trial and its Follow-up Study.

ADAPT-FS Research Group.

Alzheimers Dement. 2015 Feb;11(2):216-25.e1. doi: 10.1016/j.jalz.2014.03.009. Epub 2014 Jul 9.

PMID:
25022541
8.

Longitudinal change in working memory as a function of APOE genotype in midlife and old age.

Greenwood PM, Espeseth T, Lin MK, Reinvang I, Parasuraman R.

Scand J Psychol. 2014 Jun;55(3):268-77. doi: 10.1111/sjop.12123.

PMID:
24853824
9.

The Alzheimer's prevention initiative composite cognitive test score: sample size estimates for the evaluation of preclinical Alzheimer's disease treatments in presenilin 1 E280A mutation carriers.

Ayutyanont N, Langbaum JB, Hendrix SB, Chen K, Fleisher AS, Friesenhahn M, Ward M, Aguirre C, Acosta-Baena N, Madrigal L, Muñoz C, Tirado V, Moreno S, Tariot PN, Lopera F, Reiman EM.

J Clin Psychiatry. 2014 Jun;75(6):652-60. doi: 10.4088/JCP.13m08927. Review.

10.

An empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer's disease.

Langbaum JB, Hendrix SB, Ayutyanont N, Chen K, Fleisher AS, Shah RC, Barnes LL, Bennett DA, Tariot PN, Reiman EM.

Alzheimers Dement. 2014 Nov;10(6):666-74. doi: 10.1016/j.jalz.2014.02.002. Epub 2014 Apr 21.

PMID:
24751827
11.

Interaction of transactive response DNA binding protein 43 with nuclear factor κB in mild cognitive impairment with episodic memory deficits.

Ohta Y, Tremblay C, Schneider JA, Bennett DA, Calon F, Julien JP.

Acta Neuropathol Commun. 2014 Apr 1;2:37. doi: 10.1186/2051-5960-2-37.

12.

Building a pipeline to discover and validate novel therapeutic targets and lead compounds for Alzheimer's disease.

Bennett DA, Yu L, De Jager PL.

Biochem Pharmacol. 2014 Apr 15;88(4):617-30. doi: 10.1016/j.bcp.2014.01.037. Epub 2014 Feb 6. Review.

13.

The independent contributions of cognitive impairment and neuropsychiatric symptoms to everyday function in older adults.

Rog LA, Park LQ, Harvey DJ, Huang CJ, Mackin S, Farias ST.

Clin Neuropsychol. 2014;28(2):215-36. doi: 10.1080/13854046.2013.876101. Epub 2014 Feb 6.

14.

Age effects on explicit and implicit memory.

Ward EV, Berry CJ, Shanks DR.

Front Psychol. 2013 Sep 23;4:639. doi: 10.3389/fpsyg.2013.00639. eCollection 2013.

15.

The relationship between midlife and late life alcohol consumption, APOE e4 and the decline in learning and memory among older adults.

Downer B, Zanjani F, Fardo DW.

Alcohol Alcohol. 2014 Jan-Feb;49(1):17-22. doi: 10.1093/alcalc/agt144. Epub 2013 Sep 18.

16.

Postmenopausal hormone therapy is not associated with risk of all-cause dementia and Alzheimer's disease.

O'Brien J, Jackson JW, Grodstein F, Blacker D, Weuve J.

Epidemiol Rev. 2014;36:83-103. doi: 10.1093/epirev/mxt008. Epub 2013 Sep 15. Review.

17.

Practice effects and longitudinal cognitive change in normal aging vs. incident mild cognitive impairment and dementia in the Mayo Clinic Study of Aging.

Machulda MM, Pankratz VS, Christianson TJ, Ivnik RJ, Mielke MM, Roberts RO, Knopman DS, Boeve BF, Petersen RC.

Clin Neuropsychol. 2013;27(8):1247-64. doi: 10.1080/13854046.2013.836567. Epub 2013 Sep 17.

18.

BrainAGE in Mild Cognitive Impaired Patients: Predicting the Conversion to Alzheimer's Disease.

Gaser C, Franke K, Klöppel S, Koutsouleris N, Sauer H; Alzheimer's Disease Neuroimaging Initiative.

PLoS One. 2013 Jun 27;8(6):e67346. Print 2013.

19.

Faster cognitive decline in the years prior to MR imaging is associated with smaller hippocampal volumes in cognitively healthy older persons.

Fleischman DA, Yu L, Arfanakis K, Han SD, Barnes LL, Arvanitakis Z, Boyle PA, Bennett DA.

Front Aging Neurosci. 2013 Jun 5;5:21. doi: 10.3389/fnagi.2013.00021. eCollection 2013.

20.

Ushering in the study and treatment of preclinical Alzheimer disease.

Langbaum JB, Fleisher AS, Chen K, Ayutyanont N, Lopera F, Quiroz YT, Caselli RJ, Tariot PN, Reiman EM.

Nat Rev Neurol. 2013 Jul;9(7):371-81. doi: 10.1038/nrneurol.2013.107. Epub 2013 Jun 11. Review. Erratum in: Nat Rev Neurol. 2013 Aug;9(8):418.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk